Kohan R - Search Results

1

Reactive oxygen species in cancer: a paradox between pro- and anti-tumour activities.

Kohan R, Collin A, Guizzardi S, Tolosa de Talamoni N, Picotto G. Kohan R, et al. Cancer Chemother Pharmacol. 2020 Jul;86(1):1-13. doi: 10.1007/s00280-020-04103-2. Epub 2020 Jun 22. Cancer Chemother Pharmacol. 2020. PMID: 32572519 Review.

2

Melatonin Enhances Anti-tumoral Effects of Menadione on Colon Cancer Cells.

Collin A, Kohan R, Tolosa de Talamoni N, Picotto G. Collin A, et al. Among authors: kohan r. Anticancer Agents Med Chem. 2022;22(13):2411-2418. doi: 10.2174/1871520621666211207141729. Anticancer Agents Med Chem. 2022. PMID: 34875993

3

Intestinal Ca²⁺ absorption revisited: A molecular and clinical approach.

Areco VA, Kohan R, Talamoni G, Tolosa de Talamoni NG, Peralta López ME. Areco VA, et al. Among authors: kohan r. World J Gastroenterol. 2020 Jun 28;26(24):3344-3364. doi: 10.3748/wjg.v26.i24.3344. World J Gastroenterol. 2020. PMID: 32655262 Free PMC article. Review.

4

Special issue: Molecular basis of NCL.

Kohan R, Mole SE, Cotman SL. Kohan R, et al. Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2235-6. doi: 10.1016/j.bbadis.2015.06.023. Epub 2015 Jun 27. Biochim Biophys Acta. 2015. PMID: 26122823 Free article. No abstract available.

5

Congenital CLN8 disease of neuronal ceroid lipofuscinosis: a novel phenotype.

Pesaola F, Kohan R, Cismondi IA, Guelbert N, Pons P, Oller-Ramirez AM, Noher de Halac I. Pesaola F, et al. Among authors: kohan r. Rev Neurol. 2019 Feb 16;68(4):155-159. Rev Neurol. 2019. PMID: 30741402 Free article. English, Spanish.

6

Future perspectives: Moving towards NCL treatments.

Cotman SL, Mole SE, Kohan R. Cotman SL, et al. Among authors: kohan r. Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2336-8. doi: 10.1016/j.bbadis.2015.04.001. Epub 2015 Apr 7. Biochim Biophys Acta. 2015. PMID: 25857620 Free PMC article. Review.

7

Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Kohan R, Cismondi IA, Oller-Ramirez AM, Guelbert N, Anzolini TV, Alonso G, Mole SE, de Kremer DR, de Halac NI. Kohan R, et al. Curr Pharm Biotechnol. 2011 Jun;12(6):867-83. doi: 10.2174/138920111795542633. Curr Pharm Biotechnol. 2011. PMID: 21235444 Free PMC article. Review.

8

The neuronal ceroid lipofuscinoses program: A translational research experience in Argentina.

Kohan R, Pesaola F, Guelbert N, Pons P, Oller-Ramírez AM, Rautenberg G, Becerra A, Sims K, Xin W, Cismondi IA, Noher de Halac I. Kohan R, et al. Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2301-11. doi: 10.1016/j.bbadis.2015.05.003. Epub 2015 May 11. Biochim Biophys Acta. 2015. PMID: 25976102 Free article. Review.

9

An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients.

Kohan R, Cismondi IA, Kremer RD, Muller VJ, Guelbert N, Anzolini VT, Fietz MJ, Ramírez AM, Halac IN. Kohan R, et al. Clin Genet. 2009 Oct;76(4):372-82. doi: 10.1111/j.1399-0004.2009.01214.x. Clin Genet. 2009. PMID: 19793312

10

Gene symbol: CLN5. Disease: Neuronal Ceroid Lipofuscinosis, Finnish Variant.

Cismondi IA, Cannelli N, Aiello C, Santorelli FM, Kohan R, Oller Ramírez AM, Halac IN. Cismondi IA, et al. Among authors: kohan r. Hum Genet. 2008 Jun;123(5):554. Hum Genet. 2008. PMID: 20960661 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page